RELVAR ELLIPTA 200/25MCG – 30 DOSES

Relvar Ellipta (fluticasone furoate/vilanterol) is a combination inhalation powder used primarily for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The drug contains fluticasone furoate, a corticosteroid that reduces inflammation in the airways, and vilanterol, a long-acting beta-agonist (LABA) that helps to relax the muscles around the airways, making it easier to breathe.

Relvar Ellipta is typically prescribed for patients who require regular treatment to control their symptoms and improve lung function. It is administered via the Ellipta inhaler, which delivers a fixed dose of the medication. The combination of these two active ingredients helps to reduce the frequency of asthma attacks and COPD exacerbations, enhancing overall respiratory health and quality of life for patients. It is important to note that Relvar Ellipta is not intended for the immediate relief of acute bronchospasm.